An observational study in Coronary Artery Disease, sponsored by Peking University Third Hospital. Completed at 1 site in China. Open to participants aged Up to 75 Years. Per ClinicalTrials.gov, last updated 2021-07-14.
Sponsored by Peking University Third Hospital · Observational
The study explored the influencing factors of exercise adherence of home-based cardiac rehabilitation in patients with coronary artery disease.
The study used a qualitative exploratory design. Informants were recruited by purposive sampling. Semi-structured individual interviews were conducted among patients with coronary artery disease and medical professionals in home-based cardiac rehabilitation.
5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.
This study's enrollment of 26 is below the median of 336 across 1,947 observational studies indexed under Coronary Artery Disease.
Browse Coronary Artery Disease studies →Peking University Third Hospital is the lead sponsor of 735 studies on the registry; 262 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with coronary artery disease and medical professionals in home-based cardiac rehabilitation
Exclusion Criteria:
Other: interview
Other: interview
semi-structured individual interview
Influencing factors of exercise adherence
Influencing factors of exercise adherence in home-based cardiac rehabilitation
Time frame: The influencing factors of exercise adherence in home-based cardiac rehabilitation will be measured by the construct of the theory of planned behavior through study completion, an average of 5 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking University Third Hospital